FACTORS AFFECTING EFFICACY OF GASTROESOPHAGEAL REFLUX DISEASE TREATMENT WITH PROTON PUMP INHIBITORS

被引：0
|
作者：
Lazebnik, L. B. [1 ]
Bordin, D. S. [1 ]
Masharova, A. A. [1 ]
Firsova, L. D. [1 ]
Silvestrova, S. Yu. [1 ]
机构：
[1] Cent Sci Res Inst Gastroenterol, Moscow 111123, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2012年 / 84卷 / 02期
关键词：
gastroesophageal reflux disease; quality of life; mental status; PPIs pharmacokinetics; SYMPTOMS; THERAPY; PATIENT;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim. The aim of the study was to determine causes of proton pump inhibitors. (PPIs) inefficacy in some patients suffering from gastroesophageal reflux disease (GERD). Material and methods. In our study of 154 GERD patients, 50 received omeprazole. 51 - lansoprazole and 53 - pantoprazole in a standard daily dose. GERD symptoms (heartburn and regurgitation) were scored by Likert scale: the patients' quality of life (SF-36) and their mental status (SMALL) were examined. Upper gastrointestinal endoscopy. 24-h intraesophageal pH monitoring, esophageal manometry and pharmacokinetic study were performed. Results. The treatment with a standard dose of PPIs was ineffective in 21 (13.6%) patients. Causes of PPIs inefficacy in 4.5% patients were rapid PPI metabolism and in 9.1% - "driving gear" of symptoms formation related with psychic dysadaptation.
引用
收藏
页码：16 / 21
页数：6
相关论文
共 50 条
  • [31] Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    Luigi Monaco
    Antonio Brillantino
    Francesco Torelli
    Michele Schettino
    Giuseppe Izzo
    Angelo Cosenza
    Natale Di Martino
    World Journal of Gastroenterology, 2009, 15 (03) : 334 - 338
  • [32] Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    Monaco, Luigi
    Brillantino, Antonio
    Torelli, Francesco
    Schettino, Michele
    Izzo, Giuseppe
    Cosenza, Angelo
    Di Martino, Natale
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (03) : 334 - 338
  • [33] Evaluation of efficacy of proton pump inihibitors in refractory gastroesophageal reflux disease
    Kim, Eun Hye
    Lee, Donghwan
    Park, Kyungsoo
    Chung, Hyunsoo
    Lee, Hyuk
    Park, Jun Chul
    Shin, Sung Kwan
    Lee, Sang Kil
    Chung, Jae Bock
    Lee, Yong Chan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 290 - 290
  • [34] Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
    Zheng, Connor L.
    Alzghari, Saeed K.
    CUREUS, 2018, 10 (05):
  • [35] Gastric mucosa atrophy decreased the efficacy of proton pump inhibitor treatment on gastroesophageal reflux disease
    Wada, Tsuneya
    Sasaki, Makoto
    Kataoka, Hiromi
    Ogasawara, Naotaka
    Kubota, Eiji
    Mori, Yoshinori
    Shimura, Takaya
    Mizoshita, Tsutomu
    Mizushima, Takashi
    Okamoto, Yasuyuki
    Kamiya, Takeshi
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A153 - A153
  • [36] Histology of symptomatic gastroesophageal reflux disease: Is it predictive of response to proton pump inhibitors?
    Miwa, Hiroto
    Takubo, Kaiyo
    Shimatani, Tomohiko
    Furuta, Takahisa
    Oshima, Tadayuki
    Tanaka, Junji
    Aida, Junko
    Ito, Masanori
    Kurosawa, Susumu
    Joh, Takashi
    Wada, Tsuneya
    Habu, Yasuki
    Watanabe, Yusuke
    Hongo, Michio
    Chiba, Tsutomu
    Kinoshita, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 479 - 487
  • [37] Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
    Shi, Yichao
    Li, Jianfeng
    Cai, Shuntian
    Zhao, Hong
    Zhao, Huijun
    Sun, Gang
    Yang, Yunsheng
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [38] Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors
    Hershcovici, Tiberiu
    Fass, Ronnie
    CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (04) : 367 - 378
  • [39] Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors
    Tonini, M.
    Vigneri, S.
    Neri, M.
    Cuomo, R.
    Savarino, V.
    Pace, F.
    DIGESTION, 2007, 76 (3-4) : 171 - 178
  • [40] Risk Factors for Relapse of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients Previously Succeeded With Proton Pump Inhibitors Treatment
    Pacio-Quiterio, Magda Sofia
    Rodriguez-Aguilar, Jose Emilio G.
    Montiel-Jarquin, Alvaro
    Lopez-Alvarenga, Juan C.
    Sobrino-Cossio, Sergio R.
    Lopez-Colombo, Aurelio
    GASTROENTEROLOGY, 2012, 142 (05) : S590 - S591
12345